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Summary  Mazabraud’s  syndrome  is  deﬁned  as  the  combination  of  one  or  more  intramuscular
myxomas  and  ﬁbrous  dysplasia  of  bone.  The  diagnosis  is  important  given  the  increased  risk  of
malignant  transformation  of  the  bone  lesions.  We  report  a  case  in  a  56-year-old  patient  with  a
14-year follow-up  during  which  multiple  surgical  procedures  were  required  to  remove  myxomas
(present at  more  than  15  sites).  The  resected  myxomas  were  large  and  progressive.  Unique
features  in  this  case  include  the  long  follow-up  and  the  number  of  myxomas  considerably  above
the average  for  this  disease.  Eighty  other  cases  of  Mazabraud’s  syndrome  have  been  reported.
The condition  predominantly  affects  middle-aged  women  (mean  age,  44  years).  The  bone  lesions
may be  monostotic  or  polyostotic.  Mazabraud’s  syndrome  may  be  difﬁcult  to  distinguish  from
soft-tissue  sarcoma  or  neuroﬁbromatosis.  Identiﬁcation  of  the  underlying  genetic  abnormality
provides  diagnostic  conﬁrmation,  as  shown  in  our  patient.  The  management  consists  in  surgery
to remove  the  myxomas  and  magnetic  resonance  imaging  at  regular  intervals  to  monitor  the
lesions.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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CMazabraud’s  syndrome  is  deﬁned  as  the  combination  of
benign  intramuscular  myxomas  and  ﬁbrous  dysplasia  of  bone
The  ﬁrst  descriptions  were  written  by  Henschen  in  1926  [1]
and  by  Mazabraud  in  1957  and  1967  [2—5]. Both  ﬁbrous
dysplasia  and  myxoma  are  non-malignant  lesions  that  are
common  in  isolation  but  rarely  occur  in  combination.  In
2009,  Zoccali  at  al.  reported  a  case  and  found  67  additional
cases  in  the  literature  [6].  To  our  knowledge,  12  other  cases
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doi:10.1016/j.otsr.2012.04.002ave  been  reported  since  then  [7—17]. Here,  we  report  what
s  probably  the  81st  case.
ase-report
his  56-year-old  man  with  multiple  soft-tissue  masses  had
ndergone  surgical  resection  of  two  masses  in  the  right  groin
n  1997,  one  mass  in  the  left  groin  in  1998,  one  mass  in  the
eft  calf  in  1999,  and  one  mass  in  the  left  vastus  lateralis
uscle  in  2001.  The  pathological  diagnoses  were  lipoﬁbroma
r  benign  neuroﬁbroma.
When  he  presented  at  our  department  in  2005,  computed
omography  (CT)  ﬁndings  were  as  follows  (Fig.  1):
served.
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F howing  multiple,  slightly  hypodense  masses  in  the  soft  tissues.
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Figure  2  Anteroposterior  radiographs  of  both  femurs:  typi-igure  1  Computed  tomography  of  the  abdomen  and  pelvis  s
 three  masses  on  the  left  side,  one  in  the  vastus  lateralis
muscle,  another  in  the  proximal  thigh  adhering  to  the
inferior  pubic  ramus,  and  the  third  in  the  iliacus  muscle
anterior  to  the  femoral  head;
 ﬁve  masses  on  the  right  side,  consisting  of  a  small  mass  in
the  groin,  a  mass  posterior  to  the  vastus  medialis  muscle,
another  mass  located  more  distally  in  the  vastus  medialis
muscle,  and  two  masses  in  the  psoas  muscle;
 a  pleural  nodule  with  a  cortical  reaction  in  the  adjacent
right  ninth  rib  having  the  appearance  of  a  bony  spur,  and
a  subpleural  nodule  measuring  a  few  millimetres  in  size
and  located  in  the  posterolateral  part  of  the  lower  right
lobe;
and  bony  images  in  both  femurs  corresponding  to  typical
radiographic  images  of  ﬁbrous  dysplasia  (Fig.  2).
Magnetic  resonance  imaging  (MRI)  conﬁrmed  the
resence  of  multiple  intramuscular  masses  in  the  proximal
arts  of  both  lower  limbs,  ﬁve  located  on  the  left  side
nd  two  on  the  right  side.  The  largest  mass  measured  100
y  70  mm  and  was  located  in  the  left  obturator  externus
uscle,  where  it  displaced  the  pelvitrochanteric  muscles.
he  masses  were  well  deﬁned  and  strictly  intramuscular.
hey  generated  a  signal  of  ﬂuid  intensity  (low  intensity  on
1  images  and  high  intensity  on  T2  and  STIR  images)  and
xhibited  weak  post-gadolinium  enhancement  producing
cal signs  of  dysplasia  including  medullary  bone  remodelling  in
the diaphysis,  rim  sclerosis,  and  thinning  and  expansion  of  the
cortices with  no  invasion  or  periosteal  reaction.  Note  the  high-
density  zones  producing  a  ground-glass  appearance.
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Figure  3  Magnetic  resonance  imaging  appearance  of  the  bone  lesions  on  T1,  T2,  and  STIR  sequences:  ﬂuid-intensity  signal  (low
signal on  T1  images  and  high  signal  on  T2  and  STIR  images)  and  weak  post-gadolinium  enhancement  producing  a  heterogeneous
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fappearance  with  predominantly  central  enhancement.
a  heterogeneous  appearance  with  predominantly  central
uptake.  The  femoral  bone  lesions  were  typical  for  ﬁbrous
dysplasia,  with  low  signal  on  T1  images  and  moderately
high  signal  on  T2  images  (Fig.  3).
In  November  2005,  the  two  masses  in  the  proximal  left
thigh  were  removed,  both  to  relieve  patient  discomfort  and
to  obtain  pathological  conﬁrmation  of  the  diagnosis.  Upon
gross  examination,  both  masses  were  off-white  in  colour,
with  a  slippery  surface.  The  pathological  examination  iden-
tiﬁed  a  ﬁbrous  pseudocapsule,  which  had  a  translucent
gelatinous  appearance  and  a  slippery  consistency  resembling
a  wet  cake  of  soap,  with  whitish  septae  that  adhered  to
t
h
Figure  4  Magnetic  resonance  imaging:  multiple  well-deﬁned  intra
the involvement  of  the  intercostal  and  paraspinal  muscles  (top  left  p
muscles (bottom  right  panel).he knife  blade.  Microscopically,  there  was  a low-density
ellular  proliferation  consisting  of  spindle-shaped  cells,
ach  containing  ﬁbrillar  cytoplasm  on  either  side  of  a  small
egular  oval-shaped  nucleus  having  one  or  more  nucleoles.
he  extracellular  matrix  was  myxoid,  stained  by  Alcian  blue,
nd  faintly  lobulated  by  thin  ﬁbrous  septae.  The  diagnosis
as  multifocal  myxoma  arising  as  a  feature  of  polyostotic
azabraud’s  syndrome  with  ﬁbrous  dysplasia  lesions  in  both
emurs.Enlargement  of  the  masses  in  the  proximal  right
high  prompted  surgical  excision  in  2006  and  2007.  The
istological  ﬁndings  were  identical  to  those  obtained
muscular  masses  producing  high  signal  on  T2  STIR  images.  Note
anel),  both  thighs  (top  right  and  bottom  left  panels),  and  psoas
458  
Figure  5  Operative  view  of  the  mass  in  the  left  psoas  mus-
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ale, measuring  95  × 65  ×  55  mm,  with  a  homogeneous  gelatinous
ppearance  upon  gross  examination.
reviously. Serial  MRI  scans  were  obtained  between  2008
nd  2010  to  monitor  the  lesions,  which  increased  gradually
n  size,  leading  the  patient  to  present  again  at  our  clinic  in
011.  He  had  noticed  a  large  mass  in  the  lateral  left  thigh
nd  reported  left  femoral  neuralgia,  which  was  ascribed  to
 large  myxoma  in  the  psoas  muscle  with  a  substantial  ante-
ior  extension  medial  to  the  iliac  wing  (Fig.  4).  The  gross
ppearance  is  shown  in  Fig.  5.  Microscopically,  the  lesions
ere  myxomas  with  no  atypical  cells.  The  R201H  mutation  in
he  GNAS  gene  was  found  in  the  operative  specimens.  This
utation  has  been  reported  in  ﬁbrous  dysplasia  of  bone,
cCune  Albright  syndrome,  and  other  endocrine  tumours
6,18—22].
iscussion
ibrous  dysplasia  in  Mazabraud’s  syndrome  may  be  monos-
otic  or  polyostotic.  The  myxomas  typically  arise  near  the
ffected  bones,  although  there  is  no  evidence  of  continu-
ty  between  the  two  lesions  [23,24].  Mean  age  at  diagnosis
s  44  years  and  women  are  affected  twice  as  often  as
en  [6].  The  youngest  patient  was  17  years  of  age  at  the
ime  of  the  diagnosis  [25]. The  number  of  reported  cases
as  increased  over  the  years:  Cabral  et  al.  identiﬁed  35
ases  in  1998  [26], Endo  et  al.,  56  cases  in  2007  [27],
nd  Zoccali  et  al.,  68  cases  in  2009  [6].  The  most  com-
on  sites  of  myxoma  are  the  thighs,  shoulders,  buttocks,
nd  forearms.  The  ﬁbrous  dysplasia  lesions  predominantly
ffect  the  femurs,  tibias,  ribs,  pelvis,  and  skull.  Polyostotic
orms  often  occur  as  part  of  McCune  Albright  syndrome,
hich  manifests  as  endocrine  abnormalities  with  precocious
uberty  or  thyroid  dysfunction  (or  more  rarely  Cushing’s  syn-
rome,  diabetes,  acromegaly,  or  hyperparathyroidism  [28])
nd  as  skin  pigmentation  alterations  with  café-au-lait  spots
6,27,29—31].Several  hypotheses  have  been  put  forward,  including  a
hared  histological  origin  of  myxomas  and  ﬁbrous  dyspla-
ia  during  embryonic  development  [2—5,32], a  metabolic
bnormality  during  early  growth  of  bone  and  soft  tissues
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25], defective  tissue  development,  and  a  genetic  suscepti-
ility  [24]. More  recently,  genetic  and  immunohistochemical
tudies  identiﬁed  mutations  in  several  genes  including  the
NAS  gene  (20q13.2-13.3)  involved  in  cell  proliferation  [20].
ysplastic  changes  develop  in  all  the  cells  that  express  the
utation.  This  mutation  has  been  reported  in  ﬁbrous  dys-
lasia  of  bone,  McCune  Albright  syndrome,  and  a  number  of
ndocrine  tumours.  It  was  ﬁrst  described  in  McCune  Albright
yndrome  in  1991  [33], and  its  association  with  ﬁbrous  dys-
lasia  of  bone  was  conﬁrmed  in  1999  by  Bianco  and  Robley
18].  A  2001  report  describes  the  presence  of  the  GNAS
utation  in  myxomas  [21].
Before  the  introduction  of  MRI,  Mazabraud’s  syndrome
ad  to  be  differentiated  from  a  long  list  of  diagnoses
12,23,26,27].  Historically,  neuroﬁbromatosis  was  the  most
ommon  mistaken  diagnosis.  The  most  important  step  is
limination  of  malignant  tumours  such  as  soft-tissue  sar-
oma,  low-grade  osteosarcoma  complicating  a  pre-existing
one  lesion  [9],  liposarcoma,  or  any  other  malignant  tumour
aving  a  myxoid  component.  According  to  Mc  Laughlin  et  al.
14],  a  number  of  features  can  be  used  to  support  the  diagno-
is,  including  epidemiological  characteristics  (predominance
n  women  with  a  mean  age  of  44  years),  clinical  features
intramuscular  masses,  with  or  without  pain,  in  patients  with
nown  ﬁbrous  dysplasia  of  bone),  and  radiological  ﬁndings
features  typical  for  myxoma  and  ﬁbrous  dysplasia  on  radio-
raphs,  CT  scans,  and  MRI  scans).  Fibrous  dysplasia  lesions
xhibit  increased  radionuclide  uptake  during  scintigraphy
nd  a  heterogeneous  appearance  by  ultrasonography  [34].
ecently  introduced  imaging  techniques  such  as  positron-
mission  tomography  have  been  used  to  evaluate  patients
ith  Mazabraud’s  syndrome  [15]  but  are  not  warranted  in
veryday  practice  when  standard  imaging  methods  are  used
o  monitor  the  lesions  [16].
It  has  been  suggested  that  myxomas  do  not  recur  after
urgical  excision  [27]. In  contrast,  Szendroi  et  al.  reported
 high  rate  of  recurrence,  either  locally  or  in  the  adja-
ent  muscles,  with  a  time  to  recurrence  of  several  years
up  to  more  than  10  years)  indicating  a  need  for  long-term
ollow-up  [35]. Similarly,  our  patient  required  multiple  sur-
ical  procedures  (ﬁve,  to  remove  seven  myxomas)  over  more
han  14  years.
Fibrous  dysplasia  is  a  non-malignant  lesion  of  bone  that
s  usually  asymptomatic  and  solitary.  Pain  may  occur,  how-
ver,  as  well  as  deformities  such  as  scoliosis  and  shepherd’s
rook  deformity  of  the  proximal  femur  (marked  coxa  vara
roducing  apparent  widening  of  the  hips)  or  pathological
ractures  [20]. DiCaprio  and  Enneking  [20]  have  suggested
hat  patients  with  Mazabraud’s  syndrome  may  require  a
iagnostic  work-up  including  evaluation  by  an  endocri-
ologist,  radiographs,  and  whole-body  scintigraphy  or  CT;
ollowed  by  radiographs  at  6-month  intervals  given  the
ncreased  risk  of  malignant  transformation  of  the  ﬁbrous
ysplasia  lesions  to  osteosarcoma  [6,20,36],  of  8.3%  instead
f  1%  [20]. To  date,  six  cases  of  osteosarcoma  have  been
eported  [5,10,36—39]. All  the  osteosarcomas  developed  at
nusual  sites:  there  were  two  cases  each  at  the  radius,  tibia,
nd  humerus.  In  the  case  with  the  longest  follow-up  (16
ears  for  the  myxomas  and  31  years  for  the  ﬁbrous  dyspla-
ia),  malignant  transformation  did  not  occur  [35]. No  case  of
alignant  transformation  of  the  myxomas  has  been  reported
26].
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Conclusion
Unique  features  in  this  clinical  case  are  the  prolonged
follow-up,  which  is  among  the  longest  reported  to  date,  and
the  very  large  number  of  myxomas  (more  than  15)  compared
to  earlier  studies,  in  which  the  number  rarely  exceeded  ﬁve
or  was  not  speciﬁed.  Despite  the  enlargement  of  the  lesions
over  time  and  the  development  of  isolated  clinical  symp-
toms,  we  found  no  evidence  of  malignant  transformation.
Thus,  having  a  large  number  of  myxomas  may  not  constitute
a  risk  factor  for  malignant  transformation.  Nevertheless,
careful  long-term  monitoring  by  imaging  studies  is  manda-
tory,  and  we  believe  that  whole-body  MRI  is  the  best  option
at  present.  This  is  one  of  the  rare  cases  in  which  the  genetic
diagnosis  was  obtained  (GNAS  gene  mutation  in  the  ﬁbrous
dysplasia  and  myxoma  cells).
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